Related Experiment Videos

Pediatric palliative care and inpatient hospital costs: a longitudinal cohort study

Andrew G Smith1, Seth Andrews2, Susan L Bratton3

  • 1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; andrew.gerald.smith@hsc.utah.edu.

Pediatrics
|March 25, 2015
PubMed

Insights

Pediatric palliative care (PPC) may lower costs for children nearing death but increases expenses for survivors. The association between PPC and inpatient costs is complex and depends on patient outcomes.

Area of Science:

  • Healthcare Economics
  • Pediatric Oncology
  • Palliative Care Research

Background:

  • Pediatric palliative care (PPC) enhances quality of life for children with life-limiting conditions.
  • The economic impact of PPC, particularly inpatient costs, remains largely unquantified.
  • This study investigates the relationship between inpatient costs and PPC receipt in high-cost pediatric populations.

Purpose of the Study:

  • To quantify the association between inpatient costs and the receipt of pediatric palliative care (PPC) among high-cost pediatric inpatients.
  • To analyze cost differences between PPC recipients and non-recipients based on patient outcomes (death or survival).

Main Methods:

  • Analysis of the 10% most costly inpatients from a children's hospital in 2010.
  • Identification of factors associated with PPC receipt.
  • Comparison of 2010 inpatient costs between PPC recipients and non-recipients.
  • Comparison of inpatient costs during a 2-year follow-up for both deceased and surviving patients.

Main Results:

  • PPC receipt was associated with technology dependence, older age, multiple chronic conditions, PICU admission, and mortality.
  • PPC recipients incurred higher inpatient costs in 2010.
  • Among patients who died within 2 years, PPC recipients had significantly lower inpatient costs.
  • Among survivors, PPC recipients had higher inpatient costs.
  • Cost differences were not significant when controlling for patient complexity.

Conclusions:

  • The association between PPC and inpatient costs is multifaceted.
  • PPC appears to reduce costs for pediatric patients nearing the end of life.
  • Surviving patients referred to PPC often have complex chronic conditions, leading to sustained high healthcare resource utilization.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.1K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
697
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
853
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360